{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:45:19Z","timestamp":1791999919269,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA061116"],"award-info":[{"award-number":["R01DA061116"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA045499"],"award-info":[{"award-number":["R01DA045499"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007237"],"award-info":[{"award-number":["T32DA007237"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pbb.2026.174271","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:24:13Z","timestamp":1789773853000},"page":"174271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oxycodone self-administration in rats differentially alters IL-1R1 and IL-1R2 expression in the brain"],"prefix":"10.1016","volume":"269","author":[{"given":"Scott D.","family":"Dunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Memunat","family":"Abiru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McCafferty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonita","family":"Wiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Unterwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pbb.2026.174271_bb0005","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s12035-022-03144-3","article-title":"Repeated use of morphine induces anxiety by affecting a proinflammatory cytokine signaling pathway in the prefrontal cortex in rats","volume":"60","author":"Ahmadi","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.pbb.2026.174271_bb0020","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.3906\/sag-2005-256","article-title":"Anakinra, an interleukin-1 receptor antagonist, increases the morphine analgesic effect and decreases morphine tolerance development by modulating oxidative stress and endoplasmic reticulum stress in rats","volume":"50","author":"Avc\u0131","year":"2020","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.pbb.2026.174271_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cobeha.2016.12.003","article-title":"Neuroinflammation-a co-occurring phenomenon linking chronic pain and opioid dependence","volume":"13","author":"Cahill","year":"2017","journal-title":"Curr. Opin. Behav. Sci."},{"issue":"2","key":"10.1016\/j.pbb.2026.174271_bb0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12640-012-9334-7","article-title":"Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection","volume":"23","author":"Clark","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pbb.2026.174271_bb0040","doi-asserted-by":"crossref","first-page":"689453","DOI":"10.3389\/fimmu.2021.689453","article-title":"Neuroimmune and Mu-opioid receptor alterations in the mesocorticolimbic system in a sex-dependent inflammatory pain-induced alcohol relapse-like rat model","volume":"12","author":"Cuitavi","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.pbb.2026.174271_bb0045","doi-asserted-by":"crossref","first-page":"e23637","DOI":"10.1096\/fj.202302403R","article-title":"IL1\u03b2-NF\u03ba\u03b2-Myocardin signaling axis governs trophoblast-directed plasticity of vascular smooth muscle cells","volume":"38","author":"Das","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.pbb.2026.174271_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173900","article-title":"TNF-\u03b1, CXCL-1 and IL-1 \u03b2 as activators of the opioid system involved in peripheral analgesic control in mice","volume":"896","author":"Dias Quint\u00e3o","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2026.174271_bb0055","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2026.174271_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.11.004","article-title":"The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: the elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy","volume":"207","author":"Dujmovic","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pbb.2026.174271_bb0065","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","article-title":"The role of opioid receptors in immune system function","volume":"10","author":"Eisenstein","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.pbb.2026.174271_bb0070","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4049\/jimmunol.159.3.1451","article-title":"Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages","volume":"159","author":"Ferrari","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.pbb.2026.174271_bb0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.toxicon.2015.06.024","article-title":"Jararhagin-induced mechanical hyperalgesia depends on TNF-\u03b1, IL-1\u03b2 and NF\u03baB in mice","volume":"103","author":"Ferraz","year":"2015","journal-title":"Toxicon"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2026.174271_bb0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-5728(96)00021-5","article-title":"Interleukin-1 receptors type I and type II in the mouse brain: kinetics of mRNA expressions after peripheral administration of bacterial lipopolysaccharide","volume":"66","author":"Gabellec","year":"1996","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.pbb.2026.174271_bb0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bph.70206","article-title":"Troriluzole attenuates opioid intake, reinforcing efficacy, seeking behaviours, physical dependence and antinociceptive tolerance in rats","volume":"183,","author":"Galaj","year":"2025","journal-title":"Br. J. Pharmacol"},{"issue":"1","key":"10.1016\/j.pbb.2026.174271_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(99)01092-6","article-title":"Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer\u2019s disease patients","volume":"826","author":"Garlind","year":"1999","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.pbb.2026.174271_bb0095","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/NEN.0b013e3181f971e4","article-title":"Proinflammatory orientation of the interleukin 1 system and downstream induction of matrix metalloproteinase 9 in the pathophysiology of human perinatal white matter damage","volume":"69","author":"Girard","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pbb.2026.174271_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916646784","article-title":"Interleukin-1\u03b2 overproduction is a common cause for neuropathic pain, memory deficit, and depression following peripheral nerve injury in rodents","volume":"12","author":"Gui","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.pbb.2026.174271_bb0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbi.2024.01.001","article-title":"Blocking IL-17A prevents oxycodone-induced depression-like effects and elevation of IL-6 levels in the ventral tegmental area and reduces oxycodone-derived physical dependence in rats","volume":"117","author":"Inan","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.pbb.2026.174271_bb0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(95)00112-X","article-title":"Intracisternal administration of interleukin-1 beta attenuates naloxone-precipitated withdrawal in morphine-dependent mice","volume":"278","author":"Katsumata","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2026.174271_bb0115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11302-016-9525-4","article-title":"Morphine enhances IL-1\u03b2 release through toll-like receptor 4-mediated endocytic pathway in microglia","volume":"12","author":"Liang","year":"2016","journal-title":"Purinergic Signal"},{"issue":"9","key":"10.1016\/j.pbb.2026.174271_bb0120","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.4103\/1673-5374.366490","article-title":"Suppressing high mobility group box-1 release alleviates morphine tolerance via the adenosine 5\u2032-monophosphate-activated protein kinase\/heme oxygenase-1 pathway","volume":"18","author":"Lin","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.pbb.2026.174271_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1189\/jlb.1212659","article-title":"Alcohol-induced IL-1\u03b2 in the brain is mediated by NLRP3\/ASC inflammasome activation that amplifies neuroinflammation","volume":"94","author":"Lippai","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.pbb.2026.174271_bb0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbi.2019.03.016","article-title":"Methamphetamine-associated cognitive decline is attenuated by neutralizing IL-1 signaling","volume":"80","author":"Li\u015bkiewicz","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.pbb.2026.174271_bb0135","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191430","article-title":"Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases","volume":"217","author":"Mailhot","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pbb.2026.174271_bb0140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbi.2015.09.006","article-title":"IL-1 receptor signaling in the basolateral amygdala modulates binge-like ethanol consumption in male C57BL\/6J mice","volume":"51","author":"Marshall","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.pbb.2026.174271_bb0145","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00213-017-4536-6","article-title":"Oxycodone self-administration in male and female rats","volume":"234","author":"Mavrikaki","year":"2017","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2026.174271_bb0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imr.12609","article-title":"Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8","volume":"281","author":"Molgora","year":"2018","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.pbb.2026.174271_bb0155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10519-015-9714-x","article-title":"IL-4 knock out mice display anxiety-like behavior","volume":"45","author":"Moon","year":"2015","journal-title":"Behav. Genet."},{"issue":"9","key":"10.1016\/j.pbb.2026.174271_bb0160","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jnr.25199","article-title":"Microglial inflammation modulates opioid analgesic tolerance","volume":"101","author":"Pahan","year":"2023","journal-title":"J. Neurosci. Res."},{"issue":"21","key":"10.1016\/j.pbb.2026.174271_bb0165","doi-asserted-by":"crossref","first-page":"15195","DOI":"10.1016\/S0021-9258(17)36591-2","article-title":"Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity","volume":"269","author":"Perregaux","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.pbb.2026.174271_bb0170","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1016\/j.febslet.2006.10.061","article-title":"IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?","volume":"580","author":"Perrier","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pbb.2026.174271_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2012.11.006","article-title":"IL-1 receptor 2 (IL-1R2) and its role in immune regulation","volume":"32","author":"Peters","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pbb.2026.174271_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2025.106165","article-title":"IV IL-1 receptor antagonist reduces pain sensitivity and enhances brain endorphin release during a standardized, experimental, acute pain challenge: a BESH clinical trial","volume":"131","author":"Prossin","year":"2026","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.pbb.2026.174271_bb0185","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/00001756-200006050-00021","article-title":"Central infusion of interleukin-1 receptor antagonist fails to alter feeding and weight gain","volume":"11","author":"Pu","year":"2000","journal-title":"Neuroreport"},{"issue":"1\u20133","key":"10.1016\/j.pbb.2026.174271_bb0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2010.07.036","article-title":"Effects of the NOP receptor agonist Ro65\u20136570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats","volume":"645","author":"Rutten","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.pbb.2026.174271_bb0195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pain.2005.02.003","article-title":"Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance","volume":"115","author":"Shavit","year":"2005","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pbb.2026.174271_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jnc.14842","article-title":"Activation of GSK3\u03b2 induced by recall of cocaine reward memories is dependent on GluN2A\/B NMDA receptor signaling","volume":"151","author":"Shi","year":"2019","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.pbb.2026.174271_bb0205","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201452","article-title":"Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1\u03b2 release","volume":"218","author":"Starobova","year":"2021","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.pbb.2026.174271_bb0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcp.1041520202","article-title":"Interleukin 1: the patterns of translation and intracellular distribution support alternative secretory mechanisms","volume":"152","author":"Stevenson","year":"1992","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.pbb.2026.174271_bb0215","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.pbb.2026.174271_bb0220","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbb.2026.174271_bb0225","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/JIR.S266995","article-title":"Spinal TLR4\/P2X7 receptor-dependent NLRP3 inflammasome activation contributes to the development of tolerance to morphine-induced antinociception","volume":"13","author":"Wang","year":"2020","journal-title":"J. Inflamm. Res."},{"issue":"7","key":"10.1016\/j.pbb.2026.174271_bb0230","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1523\/JNEUROSCI.3723-13.2014","article-title":"Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior","volume":"34","author":"Wohleb","year":"2014","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2026.174271_bb0235","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biopsych.2014.10.026","article-title":"Inflammatory factors mediate vulnerability to a social stress-induced depressive-like phenotype in passive coping rats","volume":"78","author":"Wood","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.pbb.2026.174271_bb0240","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/cns.12310","article-title":"The effects of anakinra on focal cerebral ischemic injury in rats","volume":"20","author":"Xia","year":"2014","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.pbb.2026.174271_bb0245","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11481-018-9780-y","article-title":"Inflammasome activation by methamphetamine potentiates lipopolysaccharide stimulation of IL-1\u03b2 production in microglia","volume":"13","author":"Xu","year":"2018","journal-title":"J. NeuroImmune Pharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726001267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726001267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:53:22Z","timestamp":1791996802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305726001267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":46,"alternative-id":["S0091305726001267"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174271","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxycodone self-administration in rats differentially alters IL-1R1 and IL-1R2 expression in the brain","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"174271"}}